Insignificant difference in culture conversion between bedaquiline-containing and bedaquiline-free all-oral short regimens for multidrug-resistant tuberculosis

International Journal of Infectious Diseases(2021)

Cited 9|Views22
No score
Abstract
•The first trial to explore all-oral short regimens for MDR-TB in China.•Two optimized regimens, designed according to local conditions.•Similar high culture conversion in the early stage in both regimens.•High treatment success rate for patients who completed the treatment.•Good adherence in the pandemic of COVID-19.
More
Translated text
Key words
Multidrug-resistant,tuberculosis,treatment,outcome,safety,clinical trials
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined